secwatch.observer — SEC 8-K summary
======================================

Issuer:     REPLIGEN CORP (RGEN)
CIK:        0000730272
Form:       8-K
Filed at:   2023-08-02T23:59:59+00:00
Accession:  0001193125-23-201167
Event type: earnings
Sentiment:  negative
Materiality: 0.88
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Repligen Q2 revenue down 23%; slashes FY2023 revenue guidance to $635-$665M
---------------------------------------------------------------------------

- Q2 total revenue $159.2M (-23.3% YoY); base business revenue down 8.7%.
- GAAP diluted EPS $0.35 vs $0.88 in Q2 2022; adjusted EPS $0.53 vs $0.91.
- Full-year revenue guidance cut to $635-$665M from $720-$760M, a 27% reduction at midpoint.
- Base business now expected to decline 5-10% in FY2023 vs prior guidance of +4-8%.
- CEO cites inventory overhang and longer purchase approvals; Filtration segment most impacted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730272/000119312523201167/0001193125-23-201167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730272/000119312523201167/d472296d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-201167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer